TNF and uveitis: A good response to treatment and follow-up in a patient with uveitis because of spondyloarthropathy [57], or vitritis and macular edema completely remitting after five weeks in a Behçet patient [58], makes us think that Golimumab is a good alternative in refractory patients who do not respond to other anti-TNF-α.